Sign in
Stories
Innovative Human-relevant Datasets Presented
Share
Advancements in Technology Transforming ...
3D Printing Global Market Insights
3D Printing Market Surges: USD 67.5 Bill...
3D Printing Revolutionizes Healthcare wi...
Overview
API
Systemic Bio, a 3D Systems company, will present innovative human-relevant datasets at upcoming conferences to assess drug-induced liver injury and pharmacokinetics. Their advanced liver model aims to enhance albumin production, CYP activity, and urea production, while a novel model simultaneously assesses anti-tumor therapeutic efficacy and liver injury. This cutting-edge bioprinting technology allows for early-stage pharmaceutical drug development and the generation of human-relevant therapeutic insights.
Ask a question
How might Systemic Bio's innovative datasets impact the field of drug development and therapeutic insights?
In what ways could human-relevant datasets influence the future of pharmaceutical research and healthcare?
What are the potential implications of leveraging 3D Systems' bioprinting technology for drug development?
Article Frequency
0.2
0.4
0.6
0.8
1.0
Nov 2023
Dec 2023
Jan 2024
Coverage